ADRA2C antibody (Extracellular Domain, N-Term)
Quick Overview for ADRA2C antibody (Extracellular Domain, N-Term) (ABIN1731581)
Target
See all ADRA2C AntibodiesReactivity
Host
Clonality
Conjugate
Application
-
-
Binding Specificity
- Extracellular Domain, N-Term
-
Specificity
- Reacts with human ADRA2C
-
Cross-Reactivity (Details)
- BLAST analysis of the peptide immunogen showed no homology with other human proteins.
-
Purification
- Antigen affinity purified
-
Immunogen
- Synthetic 18 amino acid peptide from N-terminal extracellular domain of human ADRA2C. Percent identity with other species by BLAST analysis: Human (100%), Gorilla (100%), Gibbon (100%), Monkey (100%), Dog (89%), Rat (83%), Guinea pig (83%).
-
Isotype
- IgG
-
-
-
-
Application Notes
-
Working dilution: IHC - P (26 μg/mL
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- 1 mg/mL
-
Buffer
- PBS, Sodium azide 0.1 %
-
Preservative
- Sodium azide
-
Precaution of Use
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Storage
- 4 °C/-80 °C
-
Storage Comment
- Long term: -70°C, Short term: +4°C
-
-
- ADRA2C (Adrenergic, alpha-2C-, Receptor (ADRA2C))
-
Alternative Name
- ADRA2C
-
Background
- Alpha-2 adrenergic receptors mediate the catecholamine-induced inhibition of adenylate cyclase through the action of G proteins.
-
UniProt
- P18825
-
Pathways
- EGFR Signaling Pathway, cAMP Metabolic Process
Target
-